{"url_path":"/sec/bird/8-k/2026-06-17/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1653909/0001193125-26-273417-index.html","accession_number":"0001193125-26-273417","cik":"0001653909","ticker":"BIRD","issuer_name":"Smartbird, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1653909/0001193125-26-273417-index.html","primary_entity_key":"0001653909","primary_entity_name":"Smartbird, Inc."},"word_count":178,"has_tables":true,"body_markdown":"Item 7.01 Regulation FD Disclosure.\n\nOn June 17, 2026, the Company issued a press release regarding the matters described in Items 1.01 and 5.02 above, including the RSU Award granted to Dr. Carlsten. The RSU Award was not granted under the Company’s 2021 Equity Incentive Plan or any other stockholder-approved equity compensation plan and is intended to qualify as an “inducement grant” within the meaning of Nasdaq Listing Rule 5635(c)(4). A copy of the press release is attached hereto as Exhibit 99.1.\n\nThe information set forth in this Item 7.01 and Exhibit 99.1 attached hereto, is being furnished and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Item 7.01 and Exhibit 99.1 attached hereto, may not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing to this Current Report."}